Hereditary Updates on Hemochromatosis
Join Providence Cancer Institute hematology expert, Christine Johnson, M.D., for the most current information on hereditary hemochromatosis. In this live event, Dr. Johnson will discuss the latest updates and research, including a shift towards noninvasive diagnostics, advancements in understanding genotypes as risk factors, and updated screening and management strategies.
Event Details
Wednesday, September 10
12:00-12:45 p.m. PST
Online via Microsoft Teams
Register
Learning Objectives:
- Updates on screening and workup for iron overload
- Understanding genotypes as risk factors for clinical iron overload
- Who needs treatment
- Management strategies
- MASLD and alcoholic steatosis as other causes of iron overload
Event Schedule:
12:00 p.m. | Clinical Pearls (Est. 30 mins)
12:30 p.m. | Q & A Session (Est. 15 mins)
About the Oncology Lecture series
The Providence Cancer Institute virtual oncology lectures provide busy clinicians with critical updates and clinical pearls from experts they can trust. To find out more about our online clinical learnings or how we collaborate with and support referring clinicians, visit our website.
Subscribe to our Finish Cancer Through Research newsletter to keep up with the research breakthroughs reshaping cancer care.
When it's cancer, choose Providence.
About our speaker:
 |
Dr. Christine Johnson is an expert hematology oncologist who recently shifted the focus of her practice to classical hematology. Dr. Johnson brings a breadth of knowledge and advanced diagnostic skills to Providence Cancer Institute and is known for her excellence in educating clinicians and patients. Clinic locations: PCI Franz Clinic, PCI Oncology and Hematology Care Clinic – Westside |
Related news
A new cancer therapy at Providence helps immune cells stand their ground
A new generation CDK4 inhibitor study for people with HR+ HER2- breast cancer